After Market Gainers - Stocks Telegraph

COGNITION THERAPEUTICS TO HOST INVESTOR WEBCAST TO DISCUSS RESULTS FROM PROOF-OF-CONCEPT PHASE 2 SHINE STUDY OF CT1812 IN MILD-TO-MODERATE ALZHEIMER'S DISEASE AT 8:30AM ET ON MONDAY JULY 29, 2024

News

purchase, n.y., july 26, 2024 (globe newswire) -- cognition therapeutics, inc. (the “company” or “cognition”) (nasdaq: cgtx), a clinical stage company developing drugs that treat neurodegenerative disorders will host an investor webcast on monday, july 29, 2024 at 8:30a.m. et to discuss the clinical efficacy, safety and biomarker findings from the phase 2 cog0201 “shine” study. shine enrolled 153 adults with mild-to-moderate alzheimer's disease who were randomized to receive once-daily oral doses of ct1812 (100mg or 300mg) or placebo for six months. the only way to participate in the live webcast is to register online by clicking here. the event will also be archived on the investor relations section of the cognition website.

DAYDAYCOOK ANNOUNCES THE NYSE AMERICAN HAS ACCEPTED ITS PLAN TO REGAIN LISTING COMPLIANCE

News

new york, july 11, 2024 (globe newswire) -- ddc enterprise, ltd., (nyseam: ddc) (“daydaycook,” “ddc,” or the “company”), a leading multi-brand asian consumer food company, today announced that it received a notice (the “notice”) from the nyse american llc (the “nyse american”) dated july 9, 2024, notifying the company that it has accepted the company's plan to regain compliance with nyse american's continued listing standards.

STREAMLINE TODAY, PREDICT TOMORROW: MNDR'S AI-POWERED HEALTH OPERATING SYSTEM OPTIMIZES OPERATIONS AND POWERS PREDICTIVE HEALTHCARE

News

singapore, june 06, 2024 (globe newswire) -- mobile-health network solutions (nasdaq: mndr) (“manadr” or “the company”), a leading asia-pacific telehealth provider, today announces the latest major update to its cloud-based manadr ai-powered health operating system (“mhos”) designed to transform healthcare delivery on a global scale.

NEWAMSTERDAM PHARMA TO ANNOUNCE TOPLINE DATA FROM PIVOTAL PHASE 3 BROOKLYN CLINICAL TRIAL EVALUATING OBICETRAPIB IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA ON MONDAY, JULY 29, 2024

News

naarden, the netherlands and miami, july 26, 2024 (globe newswire) -- newamsterdam pharma company n.v. (nasdaq: nams or “newamsterdam” or the “company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at risk of cardiovascular disease (“cvd”) with elevated low-density lipoprotein cholesterol (“ldl-c”), for whom existing therapies are not sufficiently effective or well-tolerated, today announced it will report topline data from the company's phase 3 brooklyn clinical trial (nct05425745) on monday, july 29, 2024.

TRANSCODE THERAPEUTICS, INC. ANNOUNCES CLOSING OF PUBLIC OFFERING

News

boston, ma — july 24, 2024 — transcode therapeutics, inc. (nasdaq: rnaz) (“transcode” or the “company”), a clinical-stage rna oncology company committed to

HELIUS MEDICAL TECHNOLOGIES, INC. COMPLETES SITE PARTICIPATION ENROLLMENT FOR ITS U.S. REGISTRATIONAL PROGRAM IN STROKE

News

-- inclusion of the top neurorehabilitation centers rehabologym, neurology center of new england, and mgh institute of health professions completes site participation enrollment for the u.s. registrational program in stroke -- -- in canada, an additional study on the use of portable neuromodulation stimulator (pons®) therapy to treat stroke has started to support canadian reimbursement and u.s. approval for stroke --

PHOENIX MOTOR EXPECTS TO EXCEED ITS PREVIOUSLY ISSUED RECORD REVENUE GUIDANCE FOR Q1 2024

News

the company has rescheduled its q1 earnings call to august 15 anaheim, ca / accesswire / july 11, 2024 / phoenix motor inc. (nasdaq:pev), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, today announced updated guidance for the first quarter of 2024. the company now expects to report a record $9.4 million in revenue for the first quarter, exceeding the previously issued guidance range of $8 million to $9 million.

AILERON THERAPEUTICS TO BE INCLUDED IN THE RUSSELL MICROCAP® INDEX

News

austin, texas , july 1, 2024 /prnewswire/ -- aileron therapeutics, inc. ("aileron" or the "company") (nasdaq: alrn), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis indications, today announced that the company is set to join the russell microcap® index at the conclusion of the 2024 russell u.s. indexes annual reconstitution, effective at the open of us equity markets on monday, july 1, 2024. the annual russell u.s. indexes reconstitution captures the 4,000 largest u.s. stocks as of tuesday, april 30th, ranking them by total market capitalization.

AVID BIOSERVICES REPORTS FINANCIAL RESULTS FOR FOURTH QUARTER AND FISCAL YEAR ENDED APRIL 30, 2024

News

-- recorded fourth quarter revenue of $43.0 million – highest in company history -- -- signed $30 million in net new business resulting in backlog of $193 million --

SCORPIO GOLD APPOINTS HARRISON POKRANDT AS VP OF EXPLORATION

News

vancouver, british columbia--(newsfile corp. - june 28, 2024) - scorpio gold corporation (tsxv: sgn) (otc pink: srcrf) (fse ry9) ("scorpio", or the "company") is pleased to announce the appointment of mr. harrison pokrandt as the company's new vice president of exploration.

CONN'S, INC. ANNOUNCES RECEIPT OF DELINQUENCY NOTIFICATION LETTER FROM NASDAQ

News

the woodlands, texas, june 26, 2024 (globe newswire) -- conn's, inc. (nasdaq: conn) (“conn's” or the “company”), a specialty retailer of home goods, including furniture and mattresses, appliances, and consumer electronics, today announced that on june 20, 2024, it received a delinquency notification letter (the “notice”) from the nasdaq stock market llc (“nasdaq”), indicating that the company was not in compliance with nasdaq listing rule 5250(c)(1) (the "rule") because of the company's delay in filing its quarterly report on form 10-q for the fiscal quarter ended april 30, 2024 (the “form 10-q”) by the applicable due date required by the u.s. securities and exchange commission (the "sec"). the notice has no immediate effect on the listing or trading of the company's common stock on the nasdaq global select market.

TCJH RECEIVES NASDAQ NOTIFICATION REGARDING MINIMUM BID PRICE DEFICIENCY

News

guangzhou, china / accesswire / june 13, 2024 / top kingwin ltd ("top kingwin" or the "company") (nasdaq:tcjh) announced that it received a written notice (the "notice") from the nasdaq stock market llc ("nasdaq") on june 7, 2024. the notice notifies that the company is not in full compliance with the minimum bid price requirement set forth in nasdaq listing rules for continued listing on the nasdaq capital market.

ISPECIMEN REPORTS FIRST QUARTER 2024 RESULTS

News

lexington, mass., may 07, 2024 (globe newswire) -- ispecimen inc.  (nasdaq: ispc) (“ispecimen” or the “company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today reported its financial and operating results for the three-month period ended march 31, 2024.

PITNEY BOWES ANNOUNCES LEADERSHIP TRANSITION IN GLOBAL ECOMMERCE SEGMENT

News

stamford, conn.--(business wire)--pitney bowes inc. (nyse: pbi) (“pitney bowes” or the “company”), a global shipping and mailing company that provides technology, logistics and financial services, today announced that gregg zegras has retired as president of the company's global ecommerce segment, effective immediately. after joining pitney bowes in 2013, mr. zegras served as chief commercial officer and held other senior roles. the company thanks mr. zegras for his many years of dedication and.

NORTHANN CORP. REPORTS STRONG FIRST QUARTER 2024 FINANCIAL RESULTS

News

elk grove, calif., may 22, 2024 (globe newswire) -- northann corp. (nyse american: ncl), a leading innovator in 3d printing technology for home improvement products, announced its financial results for the first quarter ending march 31, 2024. the company reported substantial growth in revenues and significant progress in cost management and debt reduction.

GRAFTECH ANNOUNCES SECOND QUARTER 2024 EARNINGS CONFERENCE CALL AND WEBCAST

News

brooklyn heights, ohio--(business wire)--graftech international ltd. (nyse:eaf) (the “company”) will hold its second quarter 2024 earnings conference call and webcast on friday, july 26, 2024 at 10:00 a.m. (edt). the call will be hosted by senior management to discuss financial results for the second quarter ended june 30, 2024 and current business initiatives. these financial results will be released on friday, july 26, 2024 before market open and will be available on our investor relations we.

TEVOGEN BIO ISSUES LETTER TO STOCKHOLDERS HIGHLIGHTING RECENT ACHIEVEMENTS, GROWTH PLANS, AND CONSIDERATION OF A POTENTIAL SHARE BUYBACK

News

warren, n.j., july 11, 2024 (globe newswire) -- tevogen bio holding inc. (“tevogen” or “tevogen bio”) (nasdaq: tvgn), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified t cell therapeutics in oncology, neurology, and virology, today released a letter to stockholders highlighting recent achievements, growth plans, and consideration of a potential share buyback.

TOP WEALTH GROUP HOLDING LIMITED ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING

News

hong kong, april 18, 2024 (globe newswire) -- top wealth group holding limited (the “company” or “top wealth”), a hong kong-based supplier of luxury caviar products, today announced the closing of its initial public offering (the “offering”) of 2,000,000 ordinary shares at a public offering price of us$4.00 per ordinary share. the ordinary shares began trading on the nasdaq capital market on april 16, 2023, under the ticker symbol “twg.”

BIORESTORATIVE THERAPIES' CHIEF SCIENTIST NAMED NEW SECTION EDITOR OF THE PRESTIGIOUS JOURNAL OF TRANSLATIONAL MEDICINE

News

- new journal section will focus on emerging and translation work in the field of regenerative medicine - melville, n.y., july 23, 2024 (globe newswire) -- biorestorative therapies, inc. (“biorestorative”, “brtx” or the “company”) (nasdaq: brtx ), a clinical stage company focused on stem cell-based therapies, is pleased to announce that its chief scientist and vice president of research and development, francisco silva, has been named section editor of the newly launched regenerative medicine section of the journal of translational medicine.

SONOMA PHARMACEUTICALS CELEBRATES 20 YEARS OF SELLING WOUND CARE PRODUCTS IN EUROPE AND ANNOUNCES NEW DISTRIBUTOR IN UKRAINE

News

boulder, co / accesswire / july 9, 2024 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, today announces it is celebrating its 20th anniversary of selling wound care products in europe. sonoma is also proud to announce that it is expanding its distributor base in europe by adding a new partnership with smart healthcare company (shc) s.r.o.

MDJM LTD ANNOUNCES STRATEGIC COLLABORATION WITH CHONGQING TU BI BUSINESS MANAGEMENT CO., LTD., TO BOOST GLOBAL CULTURAL EXCHANGE AND EXPAND CULTURAL BUSINESS

News

letham, scotland, july 8, 2024 /prnewswire/ -- mdjm ltd (nasdaq: mdjh) (the "company" or "mdjm"), an integrated global culture-driven asset management company, today announced that its wholly owned subsidiary, mansions catering and hotel ltd  ("mansions"), a united kingdom company, wholly owned by our wholly owned subsidiary, md local global limited, a united kingdom company, has entered into a strategic cooperation agreement with chongqing tu bi business management co., ltd. ("chongqing tu bi"), an incubator of cultural and creative projects and brands based in china.

AVALON GLOBOCARE RECEIVES NOTICE FROM NASDAQ REGARDING DELAYED QUARTERLY REPORT

News

freehold, n.j., may 24, 2024 (globe newswire) -- avalon globocare corp. (“avalon” or the “company”) (nasdaq: albt), a developer of innovative cell-based technology, cellular therapy and precision diagnostics, today announced that it received a notice (the “notice”) on may 22, 2024 from the nasdaq stock market llc (“nasdaq”) stating that the company is not in compliance with the requirements for continued listing under nasdaq listing rule 5250(c)(1) (the “listing rule”) because the company has not yet filed its quarterly report on form 10-q for the fiscal quarter ended march 31, 2024 (the “quarterly report”) with the securities and exchange commission (the “sec”).

INMED TO PRESENT AT THE EMERGING GROWTH CONFERENCE

News

vancouver, british columbia--(newsfile corp. - june 10, 2024) - inmed pharmaceuticals inc. (nasdaq: inm) ("inmed" or the "company"), a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, today announced the company will be presenting at the upcoming emerging growth conference scheduled for june 12-13, 2024. inmed's ceo, mr.

CINGULATE ANNOUNCES EXERCISE OF WARRANTS FOR $1.86 MILLION GROSS PROCEEDS

News

kansas city, kan., june 28, 2024 (globe newswire) -- cingulate inc. (the “company”) (nasdaq: cing), a biopharmaceutical company utilizing its proprietary precision timed release™ (ptr™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced the entry into definitive agreements for the immediate exercise of certain outstanding series a warrants to purchase up to an aggregate of 2,125,000 shares of common stock of the company and series b warrants to purchase up to an aggregate of 1,062,500 shares of common stock of the company originally issued in february 2023, having an exercise price of $2.00 per share, at a reduced exercise price of $0.585 per share. the shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on form s-1 (no. 333-276502). the offering is expected to close on or about july 1, 2024, subject to satisfaction of customary closing conditions.

ENVISTA HOLDINGS CORPORATION ANNOUNCES KEY LEADERSHIP APPOINTMENTS

News

brea, calif. , july 15, 2024 /prnewswire/ -- envista holdings corporation (nyse: nvst) today announced the following key leadership appointments: eric hammes joins envista as chief financial officer stefan nilsson joins envista as president, nobel biocare veronica acurio joins envista as president, ormco "it is a pleasure to welcome this trio of successful leaders to envista," said paul keel, chief executive officer.

BIOATLA HIGHLIGHTED CLINICAL PROGRAM AND PIPELINE UPDATES AT VIRTUAL R&D DAY

News

san diego, july 25, 2024 (globe newswire) -- bioatla, inc. (nasdaq: bcab), a global clinical-stage biotechnology company focused on the development of conditionally active biologic (cab) antibody therapeutics for the treatment of solid tumors, today hosted a virtual r&d day on its novel conditionally and reversibly active antibody drug conjugate mecbotamab vedotin, targeting the receptor tyrosine kinase axl, and its antibody targeting ctla-4, evalstotug. the r&d day also featured renowned key opinion leaders, dr. edwin yau, dr. omid hamid and dr. ankit mangla.

HARMONY BIOSCIENCES TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024

News

plymouth meeting, pa. , july 23, 2024 /prnewswire/ -- harmony biosciences holdings, inc. (nasdaq: hrmy) today announced that it will report second quarter 2024 financial results on tuesday, august 6, 2024, before the open of the u.s. financial markets.

EXPION360 TO PRESENT AT THE NOBLE CAPITAL VIRTUAL TMT CONFERENCE ON WEDNESDAY JUNE 26, 2024

News

redmond, ore., june 12, 2024 (globe newswire) -- expion360 inc. (nasdaq: xpon) (“expion360” or the “company”), an industry leader in lithium-ion battery power storage solutions, will attend the noble capital virtual tmt conference being held virtually june 26 - 27, 2024.

99.74% RECURRENCE FREE RATE FOR WOMEN WITH BREAST CANCER TREATED WITH ICECURE'S PROSENSE® CRYOABLATION SYSTEM: KEY FINDINGS DELIVERED AT 32ND ANNUAL MEETING OF THE JAPANESE BREAST CANCER SOCIETY

News

demand for minimally invasive breast cancer treatment was overarching theme of the conference in one independent study led by professor fukuma, 389 patients treated for up to 10 years had 99.74% recurrence free rate another independent study led by professor kawamoto found 0% breast cancer local recurrence in five-year follow up prosense® expected to gain further traction in japan, as distribution partner terumo corporation plans to submit application to the pharmaceuticals and medical devices agency ("pmda") for regulatory clearance for breast cancer in the first quarter of 2025 caesarea, israel , july 22, 2024 /prnewswire/ -- icecure medical ltd. (nasdaq: iccm) ("icecure", "icecure medical" or the "company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that key findings from three clinical studies of prosense® in the treatment of breast cancer were presented at the 32nd annual meeting of the japanese breast cancer society on july 12, 2024 in miyagi, japan.

SEC CHARGES META MATERIALS AND FORMER CEOS WITH MARKET MANIPULATION, FRAUD AND OTHER VIOLATIONS

News

washington, d.c.--(newsfile corp. - june 25, 2024) - the securities and exchange commission today filed charges against meta materials inc. and its former ceos, john brda and george palikaras.

MULTI WAYS HOLDINGS SECURES $17.6 MILLION LEASING DEAL WITH SINGAPORE'S MINISTRY OF DEFENCE, STRENGTHENING ITS GROWTH PROSPECTS

News

singapore, june 14, 2024 (globe newswire) -- multi ways holdings limited (“multi ways” or the “company”) (nyse american: mwg), a leading supplier of a wide range of heavy construction equipment for sales and rental in singapore and the surrounding region, today announced a breakthrough equipment leasing agreement with the ministry of defence of singapore.

PLUS THERAPEUTICS SHOWCASES LEPTOMENINGEAL METASTASES PROGRAMS AT 2024 SNO/ASCO CONFERENCE

News

austin, texas, july 25, 2024 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv) (“plus” or the “company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (cns) cancers, will have multiple opportunities to present data at the 2024 society for neuro-oncology (sno) / american society for clinical oncology (asco) cns metastases conference august 8-10, in denver, colorado. “this year's sno/asco metastases conference is a key opportunity for plus to highlight advancements in our lm therapeutics and diagnostics programs,” said marc h.

MOBIX LABS COLLABORATES TO DEVELOP LOW-COST, ENERGY-EFFICIENT 5G BASE STATION SOLUTIONS

News

irvine, calif.--(business wire)--mobix labs inc. (nasdaq: mobx), a fabless semiconductor company specializing in next-generation connectivity solutions, today announced a strategic partnership with talkingheads wireless (thw) to develop a new generation of cost-effective, energy-efficient 5g base stations. thw's 5g radio solution uses ai technology to optimize tower energy consumption, while mobix labs' broad portfolio of products including ics, antennas, and active optical cables and transceiv.

AGEAGLE AERIAL COMPLETES EBEE VISION TRAINING EXHIBITION FOR PROMINENT DEFENSE AND PUBLIC SAFETY PARTNERS IN THE U.S.

News

participants explored and received training on all advanced capabilities of the ebee vision wichita, kan., july 25, 2024 (globe newswire) -- ageagle aerial systems inc. (nyse american: uavs) (“ageagle” or the “company”), an ​industry-leading​ provider of best-in-class full stack flight hardware, sensors, and software for commercial and government use, announces that the company has recently completed a training exhibition for key defense and public safety partners in the u.s.: darley, geoacuity, hexagon us federal, and tough stump technologies.

CARA THERAPEUTICS ANNOUNCES OUTCOME OF PART A OF KOURAGE-1 STUDY EVALUATING ORAL DIFELIKEFALIN IN NOTALGIA PARESTHETICA

News

– oral difelikefalin did not demonstrate meaningful clinical benefit compared to placebo – – company will discontinue clinical program in np and explore strategic alternatives – stamford, conn., june 12, 2024 (globe newswire) -- cara therapeutics, inc. (nasdaq: cara), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced the outcome from the dose-finding part a of the kourage-1 study evaluating the efficacy and safety of oral difelikefalin for moderate-to-severe pruritus in adult patients with notalgia paresthetica (np).

PULMATRIX ANNOUNCES CROSS LICENSE AGREEMENT AND TRANSFER OF LABORATORY TO MANNKIND CORPORATION

News

cross license involves pulmatrix isperse™ technology and mannkind's cricket® inhalation device. pulmatrix transferring leased building, all leasehold improvements, laboratory equipment and other related personal property in exchange for mannkind assumption of lease.

APTEVO THERAPEUTICS ANNOUNCES CLOSING OF $2.75 MILLION OFFERING

News

seattle, wa / accesswire / july 1, 2024 / aptevo therapeutics inc. (nasdaq:apvo), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary adaptir™ and adaptir-flex™ platform technologies, today announced the closing of its previously announced offering of (i) 5,339,806 shares of its common stock or pre-funded warrants in lieu thereof and (ii) warrants to purchase up to an aggregate of 10,679,612 shares of its common stock (the "common warrants") at a purchase price of $0.515 per share and associated common warrant in a registered direct offering priced at-the-market under nasdaq rules. each share of common stock is being offered together with two common warrants, each to purchase one share of common stock.

COLLECTIVE AUDIENCE CEO, PETER BORDES, APPOINTED TO SYMITRI'S ALL-STAR BOARD OF DIGITAL TECH EXECUTIVES AND INVESTORS

News

new york, ny / accesswire / june 24, 2024 / collective audience, inc. (nasdaq-gm:caud), an industry-leading audience-based advertising and media platform for the open web, announced that its ceo, peter bordes, was appointed to the board of directors of symitri, the world's first integrated privacy firewall and real-time data cleanroom for the open web. peter bordes as a lifelong entrepreneur, industry thought leader and venture investor, bordes brings to the board more than 30 years of experience leading private and public companies driving innovation in the adtech, media, ai, fintech and technology sectors.

CAPTIVISION TEAMS UP WITH ACTIVISION'S CALL OF DUTY®: MOBILE FOR FRAMEWORK IN THE DESERT AFTERPARTY

News

miami and seoul, april 24, 2024 (globe newswire) -- captivision inc. (nasdaq: capt), a pioneer and manufacturer of architectural media glass, today announced its collaboration with activision's call of duty: mobile and framework for the recent installation at the framework in the desert afterparty in coachella valley. through this collaboration, captivision delivered a unique media glass installation over the course of the festival.

NOVABAY PHARMACEUTICALS OFFERS 20% DISCOUNTS ON AVENOVA EYECARE PRODUCTS DURING AMAZON PRIME DAY

News

emeryville, calif.--(business wire)--novabay pharmaceuticals, inc. (nyse american: nby) announces 20% discounts on avenova®-branded eyecare products and product bundles during amazon prime day being held july 16-17, 2024. “prime day has been a highly productive event for novabay in past years and conveniently falls during national dry eye awareness month when there is increasing focus on this chronic condition that affects about 25 million americans,” said justin hall, novabay ceo. “the discoun.

IVEDA AND CLEARVIEW ASSET PROTECTION PARTNER TO ENHANCE PUBLIC SAFETY WITH ARTIFICIAL INTELLIGENCE

News

mesa, ariz.--(business wire)--iveda® (nasdaq:ivda), the global solution for cloud-based ai, today announced a collaboration with clearview asset protection to help improve local public safety systems, such as amber alerts, major interstate highways, sports stadiums, and more. leveraging ai-powered surveillance technology, ivedaai will use data from existing cameras and infrastructure to intelligently monitor and alert for threats including suspicious persons, missing or endangered children, smo.

AKOUSTIS SECURES $8 MILLION IN VOLUME XBAW® ORDERS WITH TIER-1 CUSTOMER

News

charlotte, n.c., july 09, 2024 (globe newswire) -- akoustis technologies, inc. (nasdaq: akts) (“akoustis” or the “company”), an integrated device manufacturer (idm) of patented bulk acoustic wave (baw) high-band rf filters for mobile and other wireless applications, announced today that the company has received $8m in new orders from a tier-1 customer to satisfy the customer's demand for four wi-fi access points (ap), which are either currently in production or ramping into production in the second half of calendar year 2024.

REVANCE REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

News

nashville, tenn.--(business wire)--revance reports inducement grants under nasdaq listing rule 5635(c)(4).

CONIFER HOLDINGS REPORTS 2024 FIRST QUARTER FINANCIAL RESULTS

News

company to host conference call at 8:30 am et on wednesday, may 15, 2024 company to host conference call at 8:30 am et on wednesday, may 15, 2024

GAMESQUARE CLARIFIES JULY 18, 2024 FORM S-1 FILING

News

form s-1 filed in normal course of business, and registers certain shares that have already been issued and outstanding insiders, including chairman and ceo purchased stock in the open market in june 2024 frisco, tx / accesswire / july 22, 2024 / gamesquare holdings, inc. (nasdaq:game), ("gamesquare", or the "company"), today clarified comments regarding its form s-1 that was filed with the securities and exchange commission ("sec") on thursday, july 18, 2024. justin kenna, ceo of gamesquare stated, "the s-1 filing was issued in the normal course of business and we have no current plans to raise any additional equity financing.

DOCGO INC INVESTIGATED BY THE SCHALL LAW FIRM URGES IMPACTED INVESTORS TO ENGAGE IN DIALOGUE

News

los angeles, ca / accesswire / july 26, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of docgo inc. ("docgo" or "the company") (nasdaq:dcgo) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

CHIJET MOTOR COMPANY ANNOUNCES 1-FOR-30 REVERSE STOCK SPLIT

News

new york, july 03, 2024 (globe newswire) -- chijet motor company, inc. (nasdaq: cjet) (the “company” or “chijet”), a high-tech enterprise engaged in the development, manufacture, sales, and service of traditional fuel vehicles and new energy vehicles (“nev”), announces a 1-for-30 reverse split of its ordinary shares effective june 28, 2024. beginning on july 8, 2024, the company's ordinary shares will trade on nasdaq on a split adjusted basis.

PLANET IMAGE INTERNATIONAL LIMITED ANNOUNCES CLOSING OF $5 MILLION INITIAL PUBLIC OFFERING

News

xinyu, china , jan. 29, 2024 /prnewswire/ -- planet image international limited ("planet image" or the "company") (nasdaq: yibo), an export-oriented manufacturer and seller of compatible toner cartridges based in china, the u.s. and europe, today announced the closing of its initial public offering of 1,250,000 class a ordinary shares at a public offering price of us$4.00 per share. the class a ordinary shares began trading on the nasdaq capital market under the ticker symbol "yibo" on january 25, 2024.

WHEELS UP INTRODUCES FURTHER PRICING, SAVINGS, AND REWARDS TRANSPARENCY DESIGNED TO DRIVE VALUE AND INCREASE FLEXIBILITY FOR TRAVELERS

News

wheels up's industry-leading mobile app and website will allow travelers to effectively explore dynamic rates across dates and routes while tracking savings and loyalty progress new york , july 23, 2024 /prnewswire/ -- wheels up experience inc. (nyse: up), a global leader in private aviation, is pleased to announce further updates to its recently streamlined product portfolio. as of today, the company's enhanced mobile app and website will provide increased transparency, further solidifying wheels up as the most accessible way to fly private.

VISIBLE MINERALIZATION ALLOWS MASIVO TO EXTEND DRILLING DEPTH ON HOLE FOR THE THIRD TIME

News

vancouver, british columbia--(newsfile corp. - july 16, 2024) - masivo silver corp. (tsxv: mass) (otc pink: gnypf) ("masivo" or the "company") is pleased to announce that after extending the hole target depth three times it has successfully completed drilling 456.05 feet at hole bm-24-02 or better known as hole no.2 at the boston mine, masivo's high-grade gold, silver and copper project in "elko county" in the state of nevada. "hole no.2 has shown very positive results, we are very pleased to have completed this hole after our technical team agreed to continue drilling the hole 100 feet beyond the expected depth thanks to the continuous visible high mineralization present on our drill core, this is what allowed us to extend the target depth 3 times, we are very excited to send our core to the lab for assaying," commented david coburn, president & ceo.

CEMTREX'S ADVANCED INDUSTRIAL SERVICES SECURES NEW ORDERS TOTALING $2.1 MILLION

News

hauppauge, ny, march 11, 2024 (globe newswire) --  - cemtrex inc. (nasdaq: cetx, cetxp), an advanced security technology and industrial services company, today announced it has received $2.1 million in new orders through its advanced industrial services (“ais”) subsidiary underscoring the company's strong market position and optimistic growth outlook. these orders, including a $1.6 million order for two relocation projects from a leading printing and graphics company, and a $0.5 million order to remove existing equipment for an engineering and construction company, affirm ais' commitment to delivering excellence across its service offerings.

JEFFS' BRANDS ENTERS INTO A LOI FOR EXCLUSIVE DISTRIBUTION OF ITS PEST CONTROL SOLUTIONS IN THE GULF STATES, INCLUDING THE UNITED ARAB EMIRATES

News

tel aviv, israel, july 02, 2024 (globe newswire) -- jeffs' brands ltd (“jeffs' brands” or the “company”) (nasdaq: jfbr, jfbrw), a data-driven e-commerce company operating on the amazon marketplace, announced today that its wholly-owned subsidiary fort product ltd. (“fort”) entered into a non-binding letter of intent (“loi”) with a company based in the sultanate of oman (the “partner”).this loi will serve as a base to negotiate entering into a commercial agreement with the partner, pursuant to which fort will, among other things, grant the partner an exclusive license to market, resell and distribute fort's pest control products in the gulf states, including the united arab emirates (“uae”), at the exception of on any amazon marketplace in the world, whether within or outside the gulf states, and other customary exemptions to be included in the definitive agreements and conditioned upon the partner meeting a minimum requirement as defined therewithin.

CROWN ELECTROKINETICS REGAINS COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE REQUIREMENT

News

los angeles, july 26, 2024 (globe newswire) -- crown electrokinetics corp. (nasdaq:crkn) ("crown" or the "company"), a leading smart glass technology company and an expert in constructing fiber optic networks, today announced that it has received a notification letter (the "compliance notice") from the listing qualifications department of the nasdaq stock market inc. ("nasdaq") dated july 25, 2024, informing the company that it has regained compliance with the nasdaq listing rule 5550(a)(2).

INSTACART TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 6, 2024

News

san francisco , july 16, 2024 /prnewswire/ -- instacart (nasdaq: cart) today announced it will report its second quarter 2024 financial results after market close on tuesday, august 6, 2024. the company's second quarter 2024 shareholder letter will be available on instacart's investor relations website at https://investors.instacart.com.

COSMOS HEALTH SIGNS DISTRIBUTION AGREEMENT WITH PROMED TRADING FOR ITS SKY PREMIUM LIFE FOOD SUPPLEMENTS IN QATAR

News

chicago, il / accesswire / july 25, 2024 / cosmos health inc. ("cosmos health" or the "company'') (nasdaq:cosm) , a diversified, vertically integrated global healthcare group engaged in innovative r&d, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today that it has signed a distribution agreement (the "agreement") with promed trading company ("promed") for its sky premium life food supplement products in qatar. promed, based in doha, is a leading healthcare company in qatar offering a diverse range of medical supplies and equipment, including medical and analytical devices, research and scientific instruments, beauty and health products, disposable and hospital consumables, general medical equipment, infection control products, and dental items.

FDA GRANTS PRIORITY REVIEW TO GENENTECH'S INAVOLISIB FOR ADVANCED HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER WITH A PIK3CA MUTATION

News

south san francisco, calif.--(business wire)--genentech, a member of the roche group (six: ro, rog; otcqx: rhhby), announced today that the u.s. food and drug administration (fda) has accepted the company's new drug application and granted priority review to inavolisib, an investigational oral therapy, in combination with palbociclib (ibrance®) and fulvestrant. the inavolisib-based regimen was evaluated in adult patients with pik3ca-mutated, hormone receptor (hr)-positive, human epidermal growt.

NUKKLEUS SIGNS TERM SHEET FOR ACQUISITION OF LEADING CROSS BORDER PAYMENTS FIRM MERCURY GLOBAL

News

new york--(business wire)---- $brli #fintech--nukkleus inc. (nasdaq: nukk), a pioneering force in the fintech industry, is excited to announce that it has signed a term sheet for the acquisition of mercury global, a leading cross-border payments firm with operations in london and south africa. this significant step marks nukkleus' strategic move to further strengthen its presence in the dynamic world of cross-border payments. under the proposed agreement, nukkleus is set to acquire the entire issued share capital.

REVIVA ANNOUNCES GRANT OF EUROPEAN PATENT COVERING USE OF BRILAROXAZINE FOR THE TREATMENT OF PULMONARY HYPERTENSION

News

- patent covers brilaroxazine use for treating pulmonary hypertension (ph), pulmonary arterial hypertension (pah) in any patients including treating ph in patients with chronic obstructive pulmonary disease (copd) or sickle cell disease (scd)

APOLLOMICS GRANTED 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

News

foster city, calif., july 16, 2024 (globe newswire) -- apollomics inc. (nasdaq: aplm) (“apollomics” or the “company”), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and treatment-resistant cancers, announced today that it received written notification from the nasdaq stock market llc (“nasdaq”) that it has granted the company's request for a 180-day extension to regain compliance with the continued listing requirements for the nasdaq capital market. as previously disclosed, apollomics had received a notice from nasdaq on january 16, 2024 that it is not in compliance with the bid price requirement (as defined below), because the closing bid price of the company's ordinary shares was below $1.00 per share for 30 consecutive business days.

JET.AI ANNOUNCES COMMENCEMENT OF EXCHANGE OFFER AND CONSENT SOLICITATION RELATING TO WARRANTS

News

las vegas, june 27, 2024 (globe newswire) -- jet.ai inc. (“jet.ai” or the “company”) (nasdaq: jtai), an innovative private aviation and artificial intelligence (“ai”) company, today announced the commencement of an exchange offer (the “offer”) and consent solicitation (the “consent solicitation”) relating to its outstanding (i) redeemable warrants to purchase shares of company common stock, par value $0.0001 per share (the “common stock”), which warrants trade on the nasdaq capital market under the symbol “jtaiw” (the “redeemable warrants”), (ii) merger consideration warrants to purchase shares of common stock, which warrants trade on the nasdaq capital market under the symbol “jtaiz” (the “merger consideration warrants”), and (iii) private placement warrants to purchase shares of common stock (the “private placement warrants” and, together with the redeemable warrants, and public warrants, the “warrants”). the purpose of the offer and consent solicitation is to simplify the company's capital structure and reduce the potential dilutive impact of the warrants.

OCEAN BIOMEDICAL (NASDAQ: OCEA) CONGRATULATES JOINT VENTURE PARTNER, VIRION THERAPEUTICS, ON POSITIVE IMMUNOGENICITY RESULTS FROM THEIR LEAD CHECKPOINT MODIFIER-CONTAINING IMMUNOTHERAPY, VRON-0200, FOR HBV FUNCTIONAL CURE, AT EASL 2024

News

providence, ri, june 05, 2024 (globe newswire) -- ocean biomedical, inc. (nasdaq:  ocea ), a biopharma company working to accelerate the development of compelling discoveries from top research scientists, today congratulates its jv partner virion therapeutics, llc, a clinical-stage biotechnology company developing novel t cell-based immunotherapies, on its late breaker presentation highlighting the first-ever human immunogenicity data from its novel checkpoint modifier immunotherapy for hbv functional cure (vron-0200), at the easl 2024 congress (the european association for the study of the liver), taking place in milan, italy from june 5 - 8.

SHIFTPIXY ANNOUNCES EXECUTION OF ITS SECOND ASSET PURCHASE AGREEMENT TO ACQUIRE A PROVIDER OF HUMAN CAPITAL TO SEVERAL KEY INDUSTRIAL CLIENTS ACROSS WESTERN U.S.

News

miami--(business wire)---- $pixy #gigeconomy--shiftpixy, inc. (nasdaq: pixy) (“shiftpixy” or the “company”), a florida-based national human capital provisioning enterprise which designs, manages, and sells access to a disruptive, revolutionary platform that facilitates employment in the rapidly growing gig economy, today announces the execution of its second asset purchase agreement to acquire a leading provider of human capital across the western u.s. the seller is a market leader providing recruitment, staffing an.

LOANDEPOT ADDS HOME EQUITY LOAN TO ITS EQUITYFREEDOM SUITE OF HOME EQUITY PRODUCTS

News

irvine, calif.--(business wire)-- #homemeanseverything--loandepot introduced a new home equity loan to its equityfreedom product suite.

SERES THERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(C)(4)

News

cambridge, mass, june 07, 2024 (globe newswire) -- seres therapeutics, inc. (nasdaq: mcrb) (“seres” or the “company”), a leading microbiome therapeutics company, today announced that on june 5, 2024, the compensation and talent committee of seres' board of directors granted inducement equity grants covering an aggregate of 6,188 shares of its common stock to one new employee, consisting of stock options to purchase 4,125 shares of common stock and restricted stock units (“rsus”) covering 2,063 shares of its common stock.

APTOSE ANNOUNCES RECEIPT OF DEFICIENCY NOTICE FROM NASDAQ

News

san diego and toronto, july 19, 2024 (globe newswire) -- aptose biosciences inc. (“aptose” or the “company”) (nasdaq: apto, tsx: aps), a clinical-stage precision oncology company developing highly differentiated oral targeted agents to treat hematologic malignancies, today announced that it has received a deficiency letter (the "deficiency letter") from the nasdaq listing qualifications department of the nasdaq stock market llc ("nasdaq") notifying the company that, for the last thirty (30) consecutive business days, the closing bid price for the company's common shares have been below the minimum $1.00 per share required for continued listing on the nasdaq capital market pursuant to nasdaq listing rule 5550(a)(2) (the "minimum bid price requirement").

PAINREFORM ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID PRICE NOTIFICATION

News

tel aviv, israel, may 31, 2024 (globe newswire) -- painreform ltd. (nasdaq: prfx) ("painreform" or the "company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that the company received a letter from the nasdaq listing qualifications (the “letter”), indicating that the company is not in compliance with the minimum bid price requirement for continued listing set forth in listing rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of $1.00 per share.

VINCERX PHARMA REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

News

vincerx continued to progress phase 1 dose-escalation studies for vip943, a potentially best-in-class anti-cd123 antibody-drug conjugate (adc), and vip236, a first-in-class small molecule-drug conjugate (smdc)

KIRKLAND'S HOME RECOGNIZED BY NEWSWEEK AS AMERICA'S #1 HOME GOODS & DÉCOR RETAILER

News

nashville, tenn. , july 22, 2024 /prnewswire/ -- kirkland's, inc. (nasdaq: kirk) ("kirkland's home" or the "company"), a specialty retailer of home décor and furnishings, has been recognized as america's #1 home goods & décor retailer by newsweek as part of its third annual ranking of america's best retailers.

WALLBOX ANNOUNCES PRELIMINARY ESTIMATED Q2 2024 REVENUE OF APPROXIMATELY €49 MILLION AND TIMING OF ITS SECOND QUARTER 2024 EARNINGS WEBCAST

News

barcelona, spain--(business wire)--wallbox (nyse: wbx), a leading provider of electric vehicle (ev) charging and energy management solutions worldwide, today announced preliminary second quarter 2024 revenue of approximately €49 million, representing nearly 50% year-over-year growth and double digit quarter-over-quarter growth. the primary growth driver for the second quarter was the us market, which experienced over 65% year-over-year revenue growth from increased sales of wallbox's award-winn.

LUMOS PHARMA TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS AND PROVIDE CLINICAL UPDATE ON AUGUST 1, 2024

News

austin, texas, july 23, 2024 (globe newswire) -- lumos pharma, inc. (nasdaq:lumo), a late-stage biopharmaceutical company focused on therapeutics for rare diseases, announced it will report second quarter 2024 financial results after the market close on thursday, august 1, 2024. the company will host a conference call and webcast at 4:30pm et that day to discuss these financial results and provide an update on clinical and corporate activities. a question-and-answer session will follow the prepared remarks.

SM ENERGY SCHEDULES SECOND QUARTER 2024 EARNINGS RELEASE AND CALL

News

denver , july 24, 2024 /prnewswire/ -- sm energy company (the "company") (nyse: sm) today announces that it expects to release its second quarter 2024 financial and operating results after market hours on august 7, 2024. see schedule below: august 7, 2024 – after market close, the company plans to issue its second quarter 2024 financial and operating results, which will include an earnings release, a pre-recorded webcast discussing the second quarter 2024 financial and operating results, and an associated presentation, all of which will be posted to the company's website at sm-energy.com/investors.

ASSET ENTITIES INC. ANNOUNCES REVERSE STOCK SPLIT TO REGAIN COMPLIANCE WITH NASDAQ'S MINIMUM BID PRICE

News

dallas, june 28, 2024 (globe newswire) -- asset entities inc. (“asset entities” or the “company”) (nasdaq: asst), a provider of digital marketing and content delivery services across discord and other social media platforms, and a ternary payment platform company, today announced a 1-for-5 reverse stock split (the “reverse stock split”) of its class a common stock, $0.0001 par value per share (the “class a common stock”), and its class b common stock, $0.0001 par value per share (the “class b common stock” and together with the class a common stock, the “common stock”).

MATINAS BIOPHARMA REPORTS SUCCESSFUL TREATMENT OF PATIENT WITH LIMB-THREATENING MUCOR INFECTION IN ITS ORAL MAT2203 COMPASSIONATE/EXPANDED USE ACCESS PROGRAM

News

bedminster, n.j., june 24, 2024 (globe newswire) -- matinas biopharma holdings, inc. (nyse american: mtnb), a clinical-stage biopharmaceutical company focused on delivering groundbreaking therapies using its lipid nanocrystal (lnc) platform delivery technology, announces the recent successful treatment of a 22-year-old male with polymicrobial necrotizing fasciitis (flesh-eating disease) that involved drug-resistant lichtheimia, an angio-invasive species of the fungus mucorales. this patient was treated at new york presbyterian/weill cornell medical center and was discharged after just six weeks of treatment with mat2203, matinas' oral formulation of the potent antifungal amphotericin b. the patient was treated under matinas' compassionate/ expanded use access program by sharan yadav, md, infectious disease fellow.

QUANTUM-SI ANNOUNCES PRESENTATION ON THE USE OF NEXT-GENERATION PROTEIN SEQUENCING™ TO DETECT DISEASE-RELEVANT PROTEOFORMS AT THE FESTIVAL OF GENOMICS AND BIODATA

News

branford, conn.--(business wire)--quantum-si incorporated (nasdaq: qsi) (“quantum-si,” “qsi” or the “company”), the protein sequencing company™, today announced a presentation by gloria sheynkman, ph.d., assistant professor in the department of molecular physiology and biological physics at the university of virginia at the festival of genomics and biodata conference being held in boston on june 12-13, 2024. the presentation, titled “next generation proteomics to detect disease-relevant proteof.

LIPELLA PHARMACEUTICALS ANNOUNCES COMPLETION OF SITE INITIATION VISIT FOR PHASE 2A TRIAL OF LP-310 IN ORAL LICHEN PLANUS

News

clinical testing of lp-310 expected to commence in mid-2024    patient recruitment is underway for phase 2a multicenter, dose-ranging study pittsburgh, pa., may 31, 2024 — lipella pharmaceuticals inc.

FORTRESS BIOTECH REDUCES TOTAL DEBT AND ENTERS INTO NEW $35 MILLION TERM LOAN WITH OAKTREE WITH MATURITY IN 2027

News

extends maturity of long-term debt as fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on ndas and blas in the next 12 months and potentially a fourth bla filing as early as 2025 extends maturity of long-term debt as fortress‘ late-stage pipeline continues to advance and may generate up to three regulatory approvals on ndas and blas in the next 12 months and potentially a fourth bla filing as early as 2025

TERNS PHARMACEUTICALS HIGHLIGHTS NEW PRECLINICAL DATA SUPPORTING TERN-501 IN COMBINATION WITH A GLP-1R AGONIST FOR OBESITY AT THE ADA'S 84TH ANNUAL SCIENTIFIC SESSIONS AND UPCOMING CONFERENCE PARTICIPATION

News

tern-501 significantly improved the efficacy of a glp-1 receptor agonist by normalizing energy expenditure, resulting in greater weight loss, increased fat mass loss and relative preservation of lean mass tern-501 significantly improved the efficacy of a glp-1 receptor agonist by normalizing energy expenditure, resulting in greater weight loss, increased fat mass loss and relative preservation of lean mass

HECLA ANNOUNCES DISMISSAL OF “BAD ACTOR” LAWSUIT

News

coeur d'alene, idaho--(business wire)--hecla mining company (nyse:hl) (“hecla” or “company”) today announced that the “bad actor” lawsuit impacting its libby exploration project in montana was dismissed as a result of the recent retirement of the company's former ceo phillips baker jr. on july 11, 2024, the montana first judicial district court (lewis and clark county) dismissed a lawsuit filed by environmental groups and tribes against the montana department of environmental quality (“mdeq”) a.

CARDIO DIAGNOSTICS ANNOUNCES IT'S EXHIBITING AT THE 2024 ONSITE EMPLOYEE HEALTH CLINICS FORUM

News

chicago--(business wire)--cardio diagnostics will sponsor a booth and showcase its groundbreaking cardiovascular solutions at the 2024 onsite employee health clinics forum.

ENDACE RECOGNIZED WITH 18 INDUSTRY AWARDS IN H1 2024

News

auckland, new zealand & austin, texas--(business wire)-- #endace--packet capture authority endace today announced a record haul of 18 awards during the first half of 2024. the company and its products have been honored by cloud computing magazine, cyber defense magazine info sec awards, cybersecurity excellence awards, fortress cybersecurity awards, globee annual cyber security excellence awards, and network computing magazine. “we're very pleased to be so widely recognized for providing unparalleled ent.

BAIJIAYUN GROUP LTD ANNOUNCES RECEIPT OF NASDAQ NOTICE

News

beijing , march 18, 2024 /prnewswire/ -- baijiayun group ltd ("baijiayun" or the "company") (nasdaq: rtc), a one-stop ai video solution provider, today announced that it received a notification letter dated march 14, 2024 (the "notification letter") from the listing qualifications department of the nasdaq stock market llc (the "nasdaq"), indicating that the company is not in compliance with the minimum bid price requirement set forth in rule 5450(a)(1) of the nasdaq listing rules as the closing bid price of the company's class a ordinary share (the "share") has been below us$1.00 per share for a period of 30 consecutive trading days. the notification letter has no immediate impact on the company's listing on the nasdaq global market.

GOSSAMER BIO ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)

News

san diego--(business wire)--gossamer bio, inc. (nasdaq: goss), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (pah) and pulmonary hypertension associated with interstitial lung disease (ph-ild), today announced that the compensation committee of gossamer's board of directors approved the grant, effective june 5, 2024, to one new non-executive employee of non-qualified stock option aw.

BTCS INC. LAUNCHES CHAINQ: AN AI-POWERED BLOCKCHAIN ANALYTICS PLATFORM

News

silver spring, md, july 10, 2024 (globe newswire) -- btcs inc. (nasdaq: btcs) (“btcs” or the “company”), a blockchain technology-focused company, is proud to announce the launch of chainq, its pioneering blockchain analytics platform designed to revolutionize the exploration and comprehension of certain blockchain data. chainq represents a significant leap forward in simplifying the access, querying, and analysis of blockchain data, empowering users with unprecedented accessibility and insights.

TANTECH HOLDINGS LTD REGAINS COMPLIANCE WITH NASDAQ

News

lishui, china , june 17, 2024 /prnewswire/ -- tantech holdings ltd (nasdaq: tanh) ("tantech" or the "company") announced today that it received notification from the nasdaq stock market llc ("nasdaq") confirming the company has regained compliance with the periodic filing requirement for nasdaq under listing rule 5250(c)(1). nasdaq noted this matter is now closed.

ENSERVCO CORPORATION PROVIDES FURTHER UPDATE ON PLAN TO REGAIN COMPLIANCE WITH NYSE AMERICAN LISTING STANDARDS

News

longmont, colo., june 13, 2024 (globe newswire) -- enservco corporation (nyse american: ensv) (“enservco”, or the “company”), a diversified national provider of specialized well-site services to the domestic onshore conventional and unconventional oil and gas industries, today provided a further update on its plan to regain compliance with nyse american listing standards, including the status of its previously announced planned resolution of its equity deficit (the “updated plan”). the company's management believes that timely completion of the updated plan will satisfy the stockholders' equity requirement and allow enservco to retain its listing on the nyse american exchange.

WITH TWO NEW BEHAVIORAL HEALTH CUSTOMERS, THE SOBRSURE BAND IS TRANSFORMING THE STANDARD FOR CONTINUING CARE MONITORING

News

providers citing cost-effectiveness, 24/7 reporting, passive monitoring as advantages over breathalyzers denver, co / accesswire / june 18, 2024 / sobr safe, inc. (nasdaq:sobr) ("sobrsafe"), provider of next-generation transdermal alcohol detection solutions, today announced that it has signed a hardware/software agreement with a two new behavioral health customers1. both the texas-based integrative care provider and the colorado-based recovery services provider have made initial sobrsure wearable band purchases on behalf of their clients.

LEADING RENTAL CAR COMPANY PURCHASES VERINT TIMEFLEX BOT TO REDUCE CONTACT CENTER WORKFORCE ATTRITION

News

melville, n.y.--(business wire)-- #ai--verint® (nasdaq: vrnt), the cx automation company™, announced an order for the groundbreaking verint timeflex bot from a leading u.s. car rental company. the brand purchased the timeflex bot to reduce attrition among its 400 reservations agents in the contact center. the timeflex bot provides unlimited schedule flexibility while improving schedule quality and automatically calculating the impact of shift changes based on forecasted volumes, capacity and performa.

CHEETAH NET SUPPLY CHAIN SERVICE INC. ANNOUNCES CLOSING OF $1.49 MILLION FOLLOW-ON PUBLIC OFFERING

News

charlotte, n.c., july 26, 2024 (globe newswire) -- cheetah net supply chain service inc. (“cheetah net” or the “company”) (nasdaq: ctnt), a provider of warehousing and logistics services, historically in connection with the sale of parallel-import vehicles sourced in the u.s. to be sold in the prc market, and more recently for the transportation of other goods between the u.s. and the prc, today announced the closing of its follow-on offering of 6,479,663 shares of class a common stock of approximately $1.49 million in gross proceeds, before deducting offering related fees and expenses, as previously announced on july 25, 2024.

ERASCA TO PRESENT AT UPCOMING INVESTOR CONFERENCES IN JUNE

News

san diego, may 29, 2024 (globe newswire) -- erasca, inc. (nasdaq: eras), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with ras/mapk pathway-driven cancers, today announced that jonathan e. lim, m.d., chairman, ceo, and co-founder, and david m. chacko, m.d., chief financial officer and chief business officer, will participate in the following investor conferences in june 2024, and will also participate in one-on-one investor meetings.

BOWLERO'S SUMMER SEASON PASS HITS $6 MILLION IN SALES

News

richmond, va.--(business wire)--bowlero corp. (nyse: bowl) (“bowlero” or the “company”), one of the world's premier operators of location-based entertainment announced today that its summer season pass exceeded $6 million in sales to date, marking an all-time high in pass sales for the company with over two months worth of sales opportunity remaining. this achievement highlights the growing popularity of the summer season pass and bowlero's commitment to delivering value and entertainment to it.

INVESTORS WHO LOST MONEY ON CAMBIUM NETWORKS CORPORATION(CMBM) SHOULD CONTACT LEVI & KORSINSKY ABOUT PENDING CLASS ACTION - CMBM

News

new york, ny / accesswire / july 22, 2024 / if you suffered a loss on your cambium networks corporation (nasdaq:cmbm) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cambium-networks-lawsuit-submission-form?prid=91690&wire=1 or contact joseph e. levi, esq.

CENNTRO HIGHLIGHTS DELIVERY OF ALL-ELECTRIC CLASS 4 LOGISTAR 400® TO CUSTOMERS AND DEALERS IN THE UNITED STATES

News

freehold, n.j.--(business wire)--cenntro highlights delivery of all-electric class 4 logistar 400® to customers and dealers in the united states.

NUZEE, INC. ANNOUNCES COMPLETION OF PRIVATE PLACEMENT OF CONVERTIBLE NOTE AND WARRANTS

News

vista, calif. , may 2, 2024 /prnewswire/ -- nuzee, inc. (nasdaq: nuze), a leading coffee co-packing and technology company (the "company"), today announced that on april 27, 2024 it entered into a convertible note and warrant purchase agreement (the "purchase agreement") with certain investors, providing for the sale of $320,000 aggregate principal amount of convertible promissory notes and accompanying warrants to purchase up to an additional 221,147 shares of common stock in a private placement transaction.

AUTOMOTIVE VALVE STEM SEAL MARKET VALUATION TO REACH USD 866.5 MILLION BY 2034, DRIVEN BY CONTINUED GROWTH IN AUTOMOTIVE INDUSTRY AND TECHNOLOGICAL ADVANCEMENTS | FUTURE MARKET INSIGHTS INC.

News

the united states remains a highly lucrative market for automotive valve stem seal manufacturers. according to the latest analysis, demand for automotive valve stem seals in the usa is projected to grow at a 3.7% cagr during the assessment period, driven by their crucial role in engine lubrication. the united states remains a highly lucrative market for automotive valve stem seal manufacturers. according to the latest analysis, demand for automotive valve stem seals in the usa is projected to grow at a 3.7% cagr during the assessment period, driven by their crucial role in engine lubrication.

BURGERFI TO CONSIDER STRATEGIC ALTERNATIVES

News

designates david heidecorn as successor to ophir sternberg as chairman of the board enters retention agreements with executive leadership to ensure steady leadership fort lauderdale, fla., may 30, 2024 (globe newswire) -- burgerfi international, inc. (nasdaq: bfi, bfiiw) (“burgerfi” or the “company”), owner of the high-quality, casual dining pizza brand under the name anthony's coal fired pizza & wings (“anthony's”) and one of the nation's leading fast-casual “better burger” dining concepts through the burgerfi brand, announced today several key initiatives with the goal of enhancing the company's prospects and ensuring stable management as the company goes through the process of reviewing strategic alternatives.

INCLUSIVE SUN CARE LINE, CAY SKIN, DEBUTS ON QVC

News

winnie harlow to premiere the suncare line that puts skin first live on qvc west chester, pa. , july 12, 2024 /prnewswire/ -- qvc® , world leader in live shoppable entertainment announced today it has launched cay skin.

NATURE'S MIRACLE HOLDING INC. ANNOUNCES PRICING OF $1.2 MILLION PUBLIC OFFERING

News

ontario, calif. , july 26, 2024 /prnewswire/ -- nature's miracle holding inc. (nasdaq: nmhi) ("nature's miracle" or the "company"), a leader in vertical farming technology and infrastructure, today announced the pricing of a public offering of 5,000,000 units (the "units") consisting of (i) one share of common stock, par value $ 0.0001 per share ("common stock") and (ii) one series a warrant to purchase one share of common stock ("warrant") at a public offering price of $0.24 per unit, for aggregate gross proceeds of $1.2 million, prior to deducting underwriting discounts and other offering expenses.

LOST MONEY ON ODDITY TECH LTD. (ODD)? JOIN CLASS ACTION SUIT SEEKING RECOVERY - CONTACT LEVI & KORSINSKY

News

new york, ny / accesswire / july 26, 2024 / if you suffered a loss on your oddity tech ltd. (nasdaq:odd) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/oddity-tech-lawsuit-submission-form?prid=92472&wire=1 or contact joseph e.